GAITHERSBURG, Md., July 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its second quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Wednesday, August 6, 2025. Details of the event and replay are as follows:
Conference call details: | |
Date: | August 6, 2025 |
Time: | 8:30 a.m. U.S. ET |
URL to register phone: | |
Dial-in number: | (888) 880-3330 (Domestic) or |
(+1) (646) 357-8766 (International) | |
Webcast: |
Replay details: | |
Date: | Available starting at 11:30 a.m. U.S. ET, August 6, 2025, until 11:59 p.m. U.S. ET, August 13, 2025 |
Dial-in number: | (800) 770-2030 (Domestic) or |
(+1) (609) 800-9909 (International) | |
Passcode: | 3041984# |
Webcast: | ir.novavax.com/events, until September 5, 2025 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-second-quarter-2025-financial-results-on-august-6-2025-302516855.html
SOURCE Novavax, Inc.